"Agonist\u00E9 I1-imidazolinov\u00FDch receptor\u016F a jejich u\u017Eit\u00ED v klinick\u00E9 praxi"@cs . "The prevalence of arterial hypertension seems to be around 30-45% of the general population and increases with ageing. Dramatically changed the treamtent options arterial hypertension in the last 30 years have brought about a significant benefit for patients. Only arterial hypertension caused only a few deaths per year. The enrichment palette antihypertensive drug in the late 20th century appeared imidazoline receptor agonists."@en . "4"^^ . "Agonist\u00E9 I1-imidazolinov\u00FDch receptor\u016F a jejich u\u017Eit\u00ED v klinick\u00E9 praxi" . . . "CZ - \u010Cesk\u00E1 republika" . "Agonists I1-imidazoline receptor and their use in clinical practice"@en . "Agonist\u00E9 I1-imidazolinov\u00FDch receptor\u016F a jejich u\u017Eit\u00ED v klinick\u00E9 praxi"@cs . "59755" . "imidazoline receptor agonists, hypertension, moxonidine, rilmenidine"@en . . . "Ad\u00E1mkov\u00E1, V\u011Bra" . . . "RIV/00023001:_____/13:00058704!RIV14-MZ0-00023001" . "N" . "14" . "Prevalence arteri\u00E1ln\u00ED hypertenze je v sou\u010Dasn\u00E9 dob\u011B v obecn\u00E9 populaci okolo 30-45 % a s v\u011Bkem roste. Dramaticky zm\u011Bn\u011Bn\u00E9 mo\u017Enosti l\u00E9\u010Dby arteri\u00E1ln\u00ED hypertenze v posledn\u00EDch zhruba t\u0159iceti letech p\u0159inesly nemocn\u00FDm v\u00FDrazn\u00FD prosp\u011Bch. Z d\u016Fvodu arteri\u00E1ln\u00ED hypertenze um\u00EDr\u00E1 v posledn\u00EDch letech pouze n\u011Bkolik nemocn\u00FDch. Paletu antihypertenziv obohacuj\u00ED koncem 20. stolet\u00ED i agonist\u00E9 imidazolinov\u00FDch receptor\u016F." . . "Agonist\u00E9 I1-imidazolinov\u00FDch receptor\u016F a jejich u\u017Eit\u00ED v klinick\u00E9 praxi" . "4" . . . "Medic\u00EDna po promoci" . "[09B4470F6BCF]" . . "http://www.tribune.cz/clanek/31498-agoniste-i-imidazolinovych-receptoru-a-jejich-uziti-v-klinicke-praxi" . "RIV/00023001:_____/13:00058704" . . . . "1212-9445" . "Prevalence arteri\u00E1ln\u00ED hypertenze je v sou\u010Dasn\u00E9 dob\u011B v obecn\u00E9 populaci okolo 30-45 % a s v\u011Bkem roste. Dramaticky zm\u011Bn\u011Bn\u00E9 mo\u017Enosti l\u00E9\u010Dby arteri\u00E1ln\u00ED hypertenze v posledn\u00EDch zhruba t\u0159iceti letech p\u0159inesly nemocn\u00FDm v\u00FDrazn\u00FD prosp\u011Bch. Z d\u016Fvodu arteri\u00E1ln\u00ED hypertenze um\u00EDr\u00E1 v posledn\u00EDch letech pouze n\u011Bkolik nemocn\u00FDch. Paletu antihypertenziv obohacuj\u00ED koncem 20. stolet\u00ED i agonist\u00E9 imidazolinov\u00FDch receptor\u016F."@cs . . "Agonists I1-imidazoline receptor and their use in clinical practice"@en . "1"^^ . . "1"^^ . .